COMPARATIVE ANALYSIS OF BLOOD LYMPHOCYTES OF PATIENTS WITH ACUTE AND CHRONIC MYELOID LEUKEMIA BY SURFACE AND INTRACELLULAR α1-ACID GLYCOPROTEIN AND FIBRONECTIN

G. S. Маslak


DOI: http://dx.doi.org/10.30970/sbi.0801.319

Abstract


The exposition of α1-acid glycoprotein and fibronectin on the surface and inside the lymphocytes of healthy donors and hematological patients with acute and chronic myeloid leukemia were studied. Localization of glycoproteins was determined by flow cytometry using antibodies conjugated to fluorescence label. Number of lymphocytes from α1-acid glycoprotein exposed on the surface under conditions of acute myeloid leukemia was 2.1 times higher than in patients with chronic myeloid leukemia. There is a significantly increasing of binding of antibodies to α1-acid glycoprotein both in cytosol and on the plasma membrane of lymphocytes in acute myeloid leukemia compared with the control group and patients with chronic myeloid leukemia. There is a significantly increasing of fibronectin exposition on the plasma membrane of lymphocytes and decreasing of fibronectin exponation in these cells in patients with chronic myeloid leukemia. The results revealed differences in distribution of the studied proteins inside and on plasma membrane of lymphocytes in patients with acute and chronic myeloid leukemia, which may represent changes in expression of these proteins depending on type of myeloleucosis.


Keywords


fibronectin, α1-acid glycoprotein, lymphocytes, acute myeloid leukemia, chronic myeloid leukemia

References


1. Blum S., Hug F., Hänsch G.M., Wagner C. Fibronectin on activated T lymphocytes is bound to gangliosides and is present in detergent insoluble microdomains. Immunology and Cell Biology, 2005; 83: 167-174.
https://doi.org/10.1111/j.1440-1711.2005.01318.x
PMid:15748213

2. Dirienzo W., Stefanini G.E., Miribel l.L. et al. αl-Acid glycoprotein (αI-AGP) on the membrane of human lymphocytes: possible involvement in cellular activation. Immunology Letters, 1987; 15: 167-170.
https://doi.org/10.1016/0165-2478(87)90049-6

3. Fournier T., Medjoubi N.N., Porquet D. Alpha-1-acid glycoprotein. Biochim. Biophys. Acta, 2000; 1482(1-2): 157-171.
https://doi.org/10.1016/S0167-4838(00)00153-9

4. Fuente M.T., Casanova B., Garcia-Gila M. et al. Fibronectin interaction with alpha4beta1 integrin prevents apoptosis in B cell chronic lymphocytic leukemia: correlation with Bcl-2 and Bax. Leukemia, 1999; 13(2): 266-274.
https://doi.org/10.1038/sj.leu.2401275
PMid:10025901

5. García-Muñoz A., Rodríguez M.A., Bologna-Molina R. et al. The orosomucoid 1 protein (α1 acid glycoprotein) is overexpressed in odontogenic myxoma. Proteome Sci, 2012; 10(1): 49-59.
https://doi.org/10.1186/1477-5956-10-49
PMid:22888844 PMCid:PMC3493304

6. Grivennikov S.I., Greten F.R., Karin M. Immunity, inflammation, and cancer. Cell, 2010; 140(6): 883-99.
https://doi.org/10.1016/j.cell.2010.01.025
PMid:20303878 PMCid:PMC2866629

7. Jia D., Yan M., Wang X. et al. Development of a highly metastatic model that reveals a crucial role of fibronectin in lung cancer cell migration and invasion. BMC Cancer, 2010; 10: 364-374.
https://doi.org/10.1186/1471-2407-10-364
PMid:20615257 PMCid:PMC2912267

8. Leblond V., Legendre C., Gras G. et al. Study of b1-integrin expression and fibronectin interaction profile of T lymphocytes in vitro infected with HIV. Aids Research and Human Retroviruses, 2000; 16(5): 423-433.
https://doi.org/10.1089/088922200309089
PMid:10772528

9. Lee S.Y., Lim J.W., Kim Y.M. Effect of alpha1-acid glycoprotein expressed in cancer cells on malignant characteristics. Mol. Cells, 2001; 11(3): 341-345.

10. Lee I.H., Kim I.S., Lee S.Y. Expression of a1 acid glycoprotein and inflammatory cytokines during differentiation of HL 60 cells. J. Biochem. and Mol. Biology, 2000; 33(5): 402-406.

11. Loi S., Sirtaine N., Piette F. et al. Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy. J. Clin. Oncol, 2013; 31(7): 860-867.

12. Melief C.J., Van Der Burg S.H., Toes R.E. et al. Effective therapeutic anticancer vaccines based on precision guiding of cytolytic T lymphocytes. Immunol. Rev, 2002; 188: 177-82.
https://doi.org/10.1034/j.1600-065X.2002.18816.x
PMid:12445291

13. Nzula S., Going J.J., Stott D.I. The role of B lymphocytes in breast cancer: a review and current status. Cancer Therapy, 2003; 1: 353-362.

14. Steven A., Mayer D.O., Carson L.F. et al. α-1 acid glycoprotein is an immunosuppressive factor found in ascites from ovarian carcinoma. Cancer, 1997; 80(8): 1448-1456.
https://doi.org/10.1002/(SICI)1097-0142(19971015)80:8<1448::AID-CNCR12>3.0.CO;2-5

15. Tang J. Influence of AGP on proliferation and expression of nuclear transcription factor p53 and c-myc in human breast cancer cell line MDA-MB-231. Acta Anatomica Sinica, 2012; 43(3): 387-392.

16. Wagner C., Bürger A., Radsak M. et al. Fibronectin synthesis by activated T lymphocytes: up-regulation of a surface-associated isoform with signalling function. Immunology, 2000; 99(4): 532-539.
https://doi.org/10.1046/j.1365-2567.2000.00995.x
PMid:10792500 PMCid:PMC2327190

17. Иммунология: практикум : учеб.пособие / [Ковальчук Л. В. и др.]; под ред. Л. В. Ковальчука, Г. А. Игнатьевой, Л. В. Ганковской. – М.: ГЭОТАР-Медиа, 2010. – 176 с.

18. Лаповець Л.Є., Лебедь Г.Б., Ястремська О.О. Вибрані лекції з лабораторної медицини. Гематологічні дослідження, 2013; 1: 192–193.

19. Савченко А.А., Смирнова О.В., Манчук В.Т. Метаболический статус лимфоцитов крови при хроническом миелолейкозе и хроническом лимфолейкозе. Медицинская иммунология, 2008; 1: 21–26.

20. Стекленева Н.И., Шевцова А.И. Изменение концентрации и соотношения гликоформ 1-кислого гликопротеина при онкозаболеваниях. Матеріали ІХ Українського біохімічного з’їзду (Львів, 24–27 жовтня 2006 р.), 2006; 2: 118.

21. Маслак Г.С., Машейко І.В., Кулініч А.О. та ін. Перерозподіл популяцій лейкоцитів за експресією фібронектину та альфа-1-кислого глікопротеїну при еритремії. Одес. мед. журнал, 2010; 21(6): 4–5.


Refbacks

  • There are currently no refbacks.


Copyright (c) 2014 Studia biologica

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.